Related Experiment Video
Updated: May 19, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
Onycholemmal carcinoma: a morphologic comparison of 6 reported cases
Brad E Chaser1, Krystal M Renszel, A Neil Crowson
1Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Onycholemmal carcinoma, a rare squamous cell carcinoma, can be treated with digit-sparing methods like Mohs surgery or radiation, offering an alternative to amputation. This study presents new cases and discusses these less aggressive treatment options.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Onycholemmal carcinoma is a rare subcategory of squamous cell carcinoma, frequently misdiagnosed.
- Historically, amputation was the standard treatment for affected digits.
Observation:
- This study presents 6 new cases of onycholemmal carcinoma.
- Clinical presentation included onycholysis, periungual erythema, and pain, with symptom duration of 6 months to 2 years.
- Histological examination revealed a well-differentiated, infiltrative squamous lesion with a lobulated and cystic growth pattern.
Findings:
- Mohs micrographic surgery and radiation therapy were utilized as primary treatment modalities.
- These digit-sparing treatments successfully maintained digit functionality and achieved remission in the reported cases.
- The study observed an indolent clinical course for onycholemmal carcinoma.
Implications:
- Onycholemmal carcinoma is a distinct squamous cell carcinoma originating from the nail isthmus.
- Less aggressive, digit-sparing treatments such as Mohs micrographic surgery and radiation therapy should be considered for onycholemmal carcinoma.
- These findings suggest a shift towards conservative management, preserving digit function.
More Related Videos
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
05:46Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography
Published on: December 2, 2022